Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nayan Lamba, M.D.

Co-Author

This page shows the publications co-authored by Nayan Lamba and Ayal Aizer.
Connection Strength

11.571
  1. Predictors of long-term survival among patients with brain metastases. Neuro Oncol. 2022 03 12; 24(3):494-496.
    View in: PubMed
    Score: 0.992
  2. The evolving role of systemic therapy and local, brain-directed treatment in patients with melanoma and brain metastases. Neuro Oncol. 2021 11 02; 23(11):1816-1817.
    View in: PubMed
    Score: 0.968
  3. Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol. 2021 09 01; 23(9):1447-1456.
    View in: PubMed
    Score: 0.956
  4. Emergency department visits and inpatient hospitalizations among older patients with brain metastases: a dual population- and institution-level analysis. Neurooncol Pract. 2021 Oct; 8(5):569-580.
    View in: PubMed
    Score: 0.938
  5. Population-based estimates of survival among elderly patients with brain metastases. Neuro Oncol. 2021 04 12; 23(4):661-676.
    View in: PubMed
    Score: 0.931
  6. Seizures Among Patients with Brain Metastases: A Population- and Institutional-level Analysis. Neurology. 2021 Jan 05.
    View in: PubMed
    Score: 0.914
  7. Utility of claims data for delineation of intracranial treatment among patients with brain metastases. Neuro Oncol. 2020 10 14; 22(10):1547-1548.
    View in: PubMed
    Score: 0.900
  8. Racial disparities in supportive medication use among older patients with brain metastases: a population-based analysis. Neuro Oncol. 2020 09 29; 22(9):1339-1347.
    View in: PubMed
    Score: 0.897
  9. Prescription of memantine during non-stereotactic, brain-directed radiation among patients with brain metastases: a population-based study. J Neurooncol. 2020 Jul; 148(3):509-517.
    View in: PubMed
    Score: 0.876
  10. Utility of claims data for identification of date of diagnosis of brain metastases. Neuro Oncol. 2020 04 15; 22(4):575-576.
    View in: PubMed
    Score: 0.869
  11. Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain Metastasis. World Neurosurg. 2019 Feb; 122:e1557-e1561.
    View in: PubMed
    Score: 0.789
  12. Incidence and predictors of neurologic death in patients with brain metastases. World Neurosurg. 2022 Mar 10.
    View in: PubMed
    Score: 0.248
  13. Intracerebral haemorrhage in patients with brain metastases receiving therapeutic anticoagulation. J Neurol Neurosurg Psychiatry. 2021 Mar 09.
    View in: PubMed
    Score: 0.231
  14. Socioeconomic Disparities Associated With MGMT Promoter Methylation Testing for Patients With Glioblastoma. JAMA Oncol. 2020 12 01; 6(12):1972-1974.
    View in: PubMed
    Score: 0.227
  15. Feasibility of hippocampal avoidance whole brain radiation in patients with hippocampal involvement: Data from a prospective study. Med Dosim. 2021 Spring; 46(1):21-28.
    View in: PubMed
    Score: 0.222
  16. Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis. World Neurosurg. 2020 Jan; 133:e804-e812.
    View in: PubMed
    Score: 0.210
  17. Association of Neurosurgical Resection With Development of Pachymeningeal Seeding in Patients With Brain Metastases. JAMA Oncol. 2019 May 01; 5(5):703-709.
    View in: PubMed
    Score: 0.203
  18. Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastases. Breast Cancer Res Treat. 2019 Jul; 176(1):171-179.
    View in: PubMed
    Score: 0.203
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.